Richard Kandasamy, Ph.D. obtained his Ph.D. in Bioinformatics and Biotechnology from the Institute of Bioinformatics, Bangalore, India. He was a EMBO – Marie Curie postdoctoral fellow in the laboratory of Prof. Giulio Superti-Furga at the Center for Molecular Medicine, Vienna, Austria where he focused on the application of multiOmics technologies including transcriptomics, proteomics, phosphoproteomics and interaction networks to study innate immune signaling and host-pathogen interactions. He was an Associate Professor and Group Leader at the Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway for 7 years leading an interdisciplinary research group on deciphering the molecular mechanisms underlying the activation and regulation of innate immunity, inflammation, and host response to viral infections through state-of-the-art multiOmics approaches including genome-editing technologies such as CRISPR/Cas9. Dr. Kandasamy is currently an Associate Consultant II in the Department of Laboratory Medicine and Pathology, Center for Individualized Medicine at Mayo Clinic in Rochester, Minnesota, USA where he focusses on application of machine-learning and multiOmics technologies including genome-editing, network analysis, and single-cell proteomics to understand the molecular basis of various diseases including multiple myeloma for development of novel diagnostic biomarkers and potential new therapeutics.
E-mail: kandasamy.richard AT mayo DOT edu